For instance, PTPN22, known as one the strongest risk gene to promote the development of ADs, is particularly related to systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and type 1 diabetes (T1D) (7). This evidence concerns the gene PTPN22 and systemic lupus erythematosus.